SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041706
Filing Date
2019-11-07
Accepted
2019-11-07 16:02:10
Documents
67
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbio-10q_20190930.htm 10-Q 1845781
2 EX-31.1 cbio-ex311_6.htm EX-31.1 13864
3 EX-31.2 cbio-ex312_8.htm EX-31.2 14082
4 EX-32.1 cbio-ex321_7.htm EX-32.1 9739
5 EX-32.2 cbio-ex322_9.htm EX-32.2 9446
6 GRAPHIC gq31n4wmxwr5000001.jpg GRAPHIC 22696
  Complete submission text file 0001564590-19-041706.txt   5896543

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cbio-20190930.xml EX-101.INS 1234076
8 XBRL TAXONOMY EXTENSION SCHEMA cbio-20190930.xsd EX-101.SCH 43275
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbio-20190930_cal.xml EX-101.CAL 40006
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbio-20190930_def.xml EX-101.DEF 104183
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20190930_lab.xml EX-101.LAB 333402
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20190930_pre.xml EX-101.PRE 244669
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51173 | Film No.: 191200192
SIC: 2834 Pharmaceutical Preparations